Exclusive Financial Advisor to Sytheon, Ltd.
Oppenheimer &. Co. Inc. acted as the Exclusive Financial Advisor to Sytheon, Ltd. on its sale to The Hallstar Company
Sytheon Ltd. (“Sytheon”) is an industry-leader in researching and developing well-defined, high-performance clean beauty ingredients with commercial track record of clinically-proven efficacy supported by scientific recognition, awards and patents, serving over 60 countries and utilized by over 350 brands globally across Dermocosmetic to mass market segments. Sytheon’s product applications include preventative & restorative anti-aging, scalp care, brightening & even toning, stabilizing & SPF boosting, anti-acne, and hydrating & barrier building. Sytheon is the leader in the Retinol-alternative market with its Bakuchiol product (Sytenol® A).
Hallstar is a leading global provider of specialty chemistry solutions. The company takes a collaborative approach to every engagement, delivering technical support, chemistry expertise and industry knowledge that helps its customers make the most of their products, from concepts to the first production batches. Hallstar's extensive capabilities in photostability sciences, 100% vegetable oil-extracted eco-actives and functional naturals set them apart in the field of cosmetic chemistry.
Our Consumer and Retail Team draws on its extensive domain knowledge and transaction execution experience to advise our consumer and retail clients on strategic matters and finance their growth. We cover both public and closely-held corporate clients as well as financial sponsors broadly focused on investing in the consumer and retail sectors.
This notice is provided for informational purposes only, and is not intended as a recommendation or an offer or solicitation for the purchase or sale of any security or financial instrument. Nothing contained herein shall constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such offer or solicitation would be prohibited.
This notice may contain statistical data cited from third-party sources believed to be reliable, but Oppenheimer & Co. Inc. does not represent that any such third-party statistical information is accurate or complete, and it should not be relied upon as such. All market prices, data and other information are not warranted as to completeness or accuracy and are subject to change without notice.
2024 Oppenheimer & Co. Inc. Transacts Business on all Principal Exchanges and Member SIPC 726488